Literature DB >> 28281237

Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients.

Rafael Bergesch D'Incao1, Cristiane Valle Tovo2, Vanessa Suñé Mattevi3, Diego Olschowsky Borges4, Jane Maria Ulbrich5, Gabriela Perdomo Coral2, Mauricio Jacques Ramos6, Nelson Guardiola Meinhardt6.   

Abstract

BACKGROUND: Obesity is a worldwide prevalent disease and is an underlying factor of non-alcoholic fatty liver disease (NAFLD). It has been understood as a chronic inflammatory state, being associated with the production of adipokines. The aim of this study was to analyze the levels of adipokines in the serum, visceral, and subcutaneous fat and to compare them with hepatic histopathology in morbidly obese patients.
METHODS: This is a cross-sectional observational study, which analyzed the findings of liver biopsy in patients undergoing bariatric surgery and who had performed analysis of adipokines mRNA expression (adiponectin-ADIPOQ, leptin-LEP, and resistin-RETN) in subcutaneous and visceral adipose tissue and circulating adipokines in serum. Liver biopsies performed were evaluated according to Kleiner criteria.
RESULTS: The study analyzed 25 patients undergoing bariatric surgery. The sample was composed exclusively of women. There was a predominance of NAFLD, with 21 patients (84%) with intrahepatic fat accumulation. Twelve patients presented non-alcoholic steatohepatitis (NASH). Glycated hemoglobin levels (HbA1c) were elevated in NASH patients. ADIPOQ levels were directly correlated with high-density lipoprotein (HDL) cholesterol levels and inversely correlated with triglycerides and total cholesterol. LEP levels showed an inverse relationship with the degree of steatosis, and RETN levels showed an inverse relationship with fibrosis stages.
CONCLUSION: Serum LEP levels were reduced in the presence of increased levels of intrahepatic fat, and serum levels of RETN were diminished in the presence of NASH. HbA1c levels were higher in the presence of NASH, indirectly reflecting insulin resistance. Moreover, ADIPOQ levels were related to blood lipid profile.

Entities:  

Keywords:  Adipokines; Bariatric Surgery; NAFLD; NASH; Obesity

Mesh:

Substances:

Year:  2017        PMID: 28281237     DOI: 10.1007/s11695-017-2627-4

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  46 in total

Review 1.  Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review.

Authors:  M Bekaert; X Verhelst; A Geerts; B Lapauw; P Calders
Journal:  Obes Rev       Date:  2015-11-24       Impact factor: 9.213

2.  Resistin levels in morbid obese patients following the biliopancreatic diversion surgery.

Authors:  D A de Luis; M C Terroba; L Cuellar; R Conde; D Primo; R Aller; M G Sagrado; O Izaola
Journal:  Horm Metab Res       Date:  2011-01-24       Impact factor: 2.936

3.  Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.

Authors:  Ancha Baranova; Shobha J Gowder; Karen Schlauch; Hazem Elariny; Rochelle Collantes; Arian Afendy; Janus P Ong; Zachary Goodman; Vikas Chandhoke; Zobair M Younossi
Journal:  Obes Surg       Date:  2006-09       Impact factor: 4.129

Review 4.  The evolving role of leptin and adiponectin in chronic liver diseases.

Authors:  Emmanuel Tsochatzis; George V Papatheodoridis; Athanasios J Archimandritis
Journal:  Am J Gastroenterol       Date:  2006-09-04       Impact factor: 10.864

5.  Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.

Authors:  Marianna Argentou; Dina G Tiniakos; Menelaos Karanikolas; Maria Melachrinou; Maria G Makri; Christos Kittas; Fotis Kalfarentzos
Journal:  Obes Surg       Date:  2009-07-15       Impact factor: 4.129

6.  Adiponectin and protection against type 2 diabetes mellitus.

Authors:  Joachim Spranger; Anja Kroke; Matthias Möhlig; Manuela M Bergmann; Michael Ristow; Heiner Boeing; Andreas F H Pfeiffer
Journal:  Lancet       Date:  2003-01-18       Impact factor: 79.321

Review 7.  Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Stergios A Polyzos; Konstantinos N Aronis; Jannis Kountouras; Dimitrios D Raptis; Maria F Vasiloglou; Christos S Mantzoros
Journal:  Diabetologia       Date:  2015-09-26       Impact factor: 10.122

8.  Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?

Authors:  Cem Cengiz; Yasemin Ardicoglu; Safak Bulut; Sedat Boyacioglu
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-07       Impact factor: 2.566

9.  Nonalcoholic fatty liver disease in severe obese patients, subjected to bariatric surgery.

Authors:  Alexandre Losekann; Antonio Carlos Weston; Luis Alberto de Carli; Marilia Bittencourt Espindola; Sergio Ricardo Pioner; Gabriela Perdomo Coral
Journal:  Arq Gastroenterol       Date:  2013 Oct-Dec

10.  Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.

Authors:  Raika Jamali; Abbas Arj; Mohsen Razavizade; Mohammad Hossein Aarabi
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more
  5 in total

1.  Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.

Authors:  Dongli Han; Jie Chen; Shousheng Liu; Zengzhi Zhang; Zhenzhen Zhao; Wenwen Jin; Yongning Xin
Journal:  J Clin Transl Hepatol       Date:  2021-05-17

Review 2.  Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions.

Authors:  Timon E Adolph; Christoph Grander; Felix Grabherr; Herbert Tilg
Journal:  Int J Mol Sci       Date:  2017-07-29       Impact factor: 5.923

3.  Deciphering the Relationship between Obesity and Various Diseases from a Network Perspective.

Authors:  Lei Chen; Yu-Hang Zhang; JiaRui Li; ShaoPeng Wang; YunHua Zhang; Tao Huang; Yu-Dong Cai
Journal:  Genes (Basel)       Date:  2017-12-18       Impact factor: 4.096

Review 4.  Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis.

Authors:  Diletta Overi; Guido Carpino; Antonio Franchitto; Paolo Onori; Eugenio Gaudio
Journal:  Cells       Date:  2020-03-02       Impact factor: 6.600

5.  Dim Light at Night Disturbs Molecular Pathways of Lipid Metabolism.

Authors:  Monika Okuliarova; Valentina Sophia Rumanova; Katarina Stebelova; Michal Zeman
Journal:  Int J Mol Sci       Date:  2020-09-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.